ArticleOpen life sciences2026

Treatment with ensartinib improves postoperative survival in a patient with stage IIB LUAD carrying a rare ALK mutation: case report.

Qiang Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.